Valentina Elena Giuditta valentina

Prof. Dr. Valentina Elena Giuditta valentina

Department of Comparative Biomedicine and Food Science, University of Padua, 35020 Padua, Italy
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2016 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
VVValentina Elena Giuditta valentina
Valentina Elena Giuditta valentina
KFKristina Pagh Friis
Kristina Pagh Friis
ZFZachary Fitzpatrick
Zachary Fitzpatrick
CMCasey A. Maguire
Casey A. Maguire
XBXandra O. Breakefield
Xandra O. Breakefield
Extracellular vesicles (EVs, including exosomes) are implicated in many aspects of nervous system development and function, including regulation of synaptic communication, synaptic strength, and nerve regeneration. They mediate the transfer of packets of information in the form of nonsecreted proteins and DNA/RNA protected within a membrane compartment. EVs are essential for the packaging and transport of many cell-fate proteins during development as well as many neurotoxic misfolded proteins during pathogenesis. This form of communication provides another dimension of cellular crosstalk, with the ability to assemble a “kit” of directional instructions made up of different molecular entities and address it to specific recipient cells. This multidimensional form of communication has special significance in the nervous system. How EVs help to orchestrate the wiring of the brain while allowing for plasticity associated with learning and memory and contribute to regeneration and degeneration are all under investigation. Because they carry specific disease-related RNAs and proteins, practical applications of EVs include potential uses as biomarkers and therapeutics. This Review describes our current understanding of EVs and serves as a springboard for future advances, which may reveal new important mechanisms by which EVs in coordinate brain and body function and dysfunction.

27 March 2009 in BMC Genomics
Verified
Journal Article
Open access
PDF file
PUPaolo Uva
Paolo Uva
LALuigi Aurisicchio
Luigi Aurisicchio
JWJames Watters
James Watters
ALAndrey Loboda
Andrey Loboda
AKAmit Kulkarni
Amit Kulkarni
EREmanuele de Rinaldis
Emanuele de Rinaldis
Background: Spontaneous tumors in dog have been demonstrated to share many features with their human counterparts, including relevant molecular targets, histological appearance, genetics, biological behavior and response to conventional treatments. Mammary tumors in dog therefore provide an attractive alternative to more classical mouse models, such as transgenics or xenografts, where the tumour is artificially induced. To assess the extent to which dog tumors represent clinically significant human phenotypes, we performed the first genome-wide comparative analysis of transcriptional changes occurring in mammary tumors of the two species, with particular focus on the molecular pathways involved.Results: We analyzed human and dog gene expression data derived from both tumor and normal mammary samples. By analyzing the expression levels of about ten thousand dog/human orthologous genes we observed a significant overlap of genes deregulated in the mammary tumor samples, as compared to their normal counterparts. Pathway analysis of gene expression data revealed a great degree of similarity in the perturbation of many cancer-related pathways, including the 'PI3K/AKT', 'KRAS', 'PTEN', 'WNT-beta catenin' and 'MAPK cascade'. Moreover, we show that the transcriptional relationships between different gene signatures observed in human breast cancer are largely maintained in the canine model, suggesting a close interspecies similarity in the network of cancer signalling circuitries.Conclusion: Our data confirm and further strengthen the value of the canine mammary cancer model and open up new perspectives for the evaluation of novel cancer therapeutics and the development of prognostic and diagnostic biomarkers to be used in clinical studies.

1 February 2020 in Cell Reports
Verified
Journal Article
Open access
RLRocco Lucero
Rocco Lucero
VVValentina Elena Giuditta valentina
Valentina Elena Giuditta valentina
ASAlessandro Sammarco
Alessandro Sammarco
OMOscar D. Murillo
Oscar D. Murillo
PCPike See Cheah
Pike See Cheah
AMAleksandar Milosavljevic
Aleksandar Milosavljevic
Glioblastoma (GBM) is characterized by aberrant vascularization and a complex tumor microenvironment. The failure of anti-angiogenic therapies suggests pathways of GBM neovascularization, possibly attributable to glioblastoma stem cells (GSCs) and their interplay with the tumor microenvironment. It has been established that GSC-derived extracellular vesicles (GSC-EVs) and their cargoes are proangiogenic in vitro. To further elucidate EV-mediated mechanisms of neovascularization in vitro, we perform RNA-seq and DNA methylation profiling of human brain endothelial cells exposed to GSC-EVs. To correlate these results to tumors in vivo, we perform histoepigenetic analysis of GBM molecular profiles in the TCGA collection. Remarkably, GSC-EVs and normal vascular growth factors stimulate highly distinct gene regulatory responses that converge on angiogenesis. The response to GSC-EVs shows a footprint of post-transcriptional gene silencing by EV-derived miRNAs. Our results provide insights into targetable angiogenesis pathways in GBM and miRNA candidates for liquid biopsy biomarkers.

16 April 2014 in Veterinary Pathology
Verified
Journal Article
Open access
PDF file
VVValentina Elena Giuditta valentina
Valentina Elena Giuditta valentina
RRR. Rasotto
R. Rasotto
DCD. Caliari
D. Caliari
MMM. Mainenti
M. Mainenti
LFLaura Peña Fernández
Laura Peña Fernández
MKMatti Kiupel
Matti Kiupel
A large number of studies have investigated feline mammary tumors in an attempt to identify prognostic markers and generate comparative analyses with human breast cancer. Nevertheless, a retrospective base of assessments and the lack of standardization in methodology and study design have caused weakness in study results, making comparison difficult. We examined feline mammary tumor publications and evaluated postulated prognostic parameters according to the recently published “Recommended Guidelines for the Conduct and Evaluation of Prognostic Studies in Veterinary Oncology.” Using these criteria, we determined with statistically significant reliability that prognostic parameters for feline mammary tumors are tumor grading and lymph node/lymphovascular invasion. Furthermore, tumor subtype, size, and staging are worthy of further standardized investigation. We present statistical significance for each studied parameter as well as its relevance to disease progression and survival. Our evaluation suggests that marker expression (ie, Ki67, HER2, ER) may provide relevant information applicable for therapeutic predictions; however, consensus efforts and protocol standardization are needed. We identify and discuss major points of concern—such as sample preservation and selection, standardization of immunohistochemical protocols, and evaluation of results—to provide support for subsequent reliable analyses.

29 December 2022 in Biosensors
Verified
Journal Article
Open access
PDF file
Alessio MeggiolaroAlessio Meggiolaro
Alessio Meggiolaro
VMValentina Moccia
Valentina Moccia
Paola BrunPaola Brun
Paola Brun
MPMatteo Pierno
Matteo Pierno
Giampaolo MisturaGiampaolo Mistura
Giampaolo Mistura
Dipartimento FerraroDipartimento Ferraro
Dipartimento Ferraro
Extracellular vesicles (EVs) are double-layered lipid membrane vesicles released by cells. Currently, EVs are attracting a lot of attention in the biological and medical fields due to their role as natural carriers of proteins, lipids, and nucleic acids. Thus, they can transport useful genomic information from their parental cell through body fluids, promoting cell-to-cell communication even between different organs. Due to their functionality as cargo carriers and their protein expression, they can play an important role as possible diagnostic and prognostic biomarkers in various types of diseases, e.g., cancers, neurodegenerative, and autoimmune diseases. Today, given the invaluable importance of EVs, there are some pivotal challenges to overcome in terms of their isolation. Conventional methods have some limitations: they are influenced by the starting sample, might present low throughput and low purity, and sometimes a lack of reproducibility, being operator dependent. During the past few years, several microfluidic approaches have been proposed to address these issues. In this review, we summarize the most important microfluidic-based devices for EV isolation, highlighting their advantages and disadvantages compared to existing technology, as well as the current state of the art from the perspective of the use of these devices in clinical applications.

18 September 2020 in Animals
Verified
Journal Article
Open access
PDF file
GBGiovanni Pietro Burrai
Giovanni Pietro Burrai
AGAndrea Gabrieli
Andrea Gabrieli
VMValentina Moccia
Valentina Moccia
VVValentina Elena Giuditta valentina
Valentina Elena Giuditta valentina
Ilaria PorcellatoIlaria Porcellato
Ilaria Porcellato
EAElisabetta Antuofermo
Elisabetta Antuofermo
Canine mammary tumors (CMTs) represent a serious issue in worldwide veterinary practice and several risk factors are variably implicated in the biology of CMTs. The present study examines the relationship between risk factors and histological diagnosis of a large CMT dataset from three academic institutions by classical statistical analysis and supervised machine learning methods. Epidemiological, clinical, and histopathological data of 1866 CMTs were included. Dogs with malignant tumors were significantly older than dogs with benign tumors (9.6 versus 8.7 years, p < 0.001). Malignant tumors were significantly larger than benign counterparts (2.69 versus 1.7 cm, p < 0.001). Interestingly, 18% of malignant tumors were smaller than 1 cm in diameter, providing compelling evidence that the size of the tumor should be reconsidered during the assessment of the TNM-WHO clinical staging. The application of the logistic regression and the machine learning model identified the age and the tumor’s size as the best predictors with an overall diagnostic accuracy of 0.63, suggesting that these risk factors are sufficient but not exhaustive indicators of the malignancy of CMTs. This multicenter study increases the general knowledge of the main epidemiologica-clinical risk factors involved in the onset of CMTs and paves the way for further investigations of these factors in association with CMTs and in the application of machine learning technology.